Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer
“Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer”, vol. 11, pp. 4034-4042, 2012.
, Different treatment outcomes and prognoses in patients with breast cancer can be observed with similar clinical predictors; this is because the biology of breast cancer is complex and heterogenous, involving multiple unknown contributing factors. We looked for plasma human mammaglobin (hMAM) mRNA by RT-PCR in 82 Korean patients with breast cancer to determine if there is an association between the presence of plasma hMAM mRNA in these patients and known prognostic factors.